Editorial Recommendations of the Month

Key articles from high impact journals in last month

December 2020

Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis

Dulai PS, Singh S, Casteele NV, Meserve J, Winters A, Chablaney S, Aniwan S, Shashi P, Kochhar G, Weiss A, Koliani-Pace JL, Gao Y, Boland BS, Chang JT, Faleck D, Hirten R, Ungaro R, Lukin D, Sultan K, Hudesman D, Chang S, Bohm M, Varma S, Fischer M, Shmidt E, Swaminath A, Gupta N, Rosario M, Jairath V, Guizzetti L, Feagan BG, Siegel CA, Shen B, Kane S, Loftus EV Jr, Sandborn WJ, Sands BE, Colombel JF, Lasch K, Cao C, Published December, 2020 in the Clinical Gastroenterology & Hepatology

Comparison of Disease Phenotypes and Clinical Characteristics Among South Asian and White Patients with Inflammatory Bowel Disease at a Tertiary Referral Center

Vimal Bodiwala, MD, Timothy Marshall, PhD, Kiron M Das, MD, PhD, Steven R Brant, MD, Darren N Seril, MD, PhD
Published December, 2020 in the Inflammatory Bowel Diseases Journal

Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease

Scott McHenry, MD, Ankita Tirath, MD, Richard Tsai, MD, Yeshika Sharma, MD, Avegail G Flores, MD, Nicholas O Davidson, MD, DSc, Kathryn J Fowler, MD, Matthew A Ciorba, MD, Parakkal Deepak, Published December 2020 in the Inflammatory Bowel Diseases Journal

Segmental colectomy for ulcerative colitis: is there a place in selected patients without active colitis? An international multicentric retrospective study in 72 patients

A Frontali, L Cohen, V Bridoux, P Myrelid, G Sica, Published December 2020 in the Journal of Crohn's and Colitis

Highly bioavailable curcumin derivative ameliorates Crohn's disease symptoms: A randomized, double-blind, multicenter study

Ken Sugimoto, Kentaro Ikeya, Shigeki Bamba, Akira Andoh, Hiroshi Yamasaki

Published December, 2020 in the Journal of Crohn's and Colitis

Safety and optimal timing of BCG vaccination in infants born to mothers receiving anti-TNF therapy for inflammatory bowel disease

Sang Hyoung Park, Hyo Jong Kim, Chang Kyun Lee, Eun Mi Song, Sang-Bum Kang, Byung Ik Jang, Eun Soo Kim, Kyeong Ok Kim, Yoo Jin Lee, Eun Young Kim, Yun Jin Jung, Soo-Kyung Park, Dong Il Park, Byong Duk Ye, Sung-Ae Jung, Suk-Kyun Yang, Published December, 2020 in the Journal of Crohn's and Colitis

Pre-treatment magnetic resonance enterography findings predict the response to TNF-alpha inhibitors in Crohn's disease

Jordi Rimola  Agnès Fernàndez‐Clotet  Nunzia Capozzi  Sònia Rojas‐Farreras  Ignacio Alfaro  Sonia Rodríguez  Maria‐Carme Masamunt  Elena Ricart  Ingrid Ordás  Julian Panés, Published December, 2020 in the Alimentary Pharmacology & Therapeutics

Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study

Robert Battat  Niels Vande Casteele  Rish K. Pai  Zhongya Wang  Guangyong Zou  John W. D. McDonald  Marjolijn Duijvestein  Jenny Jeyarajah  Claire E. Parker, Published December, 2020 in the Alimentary Pharmacology & Therapeutics

Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis

Fairbrass KM, Costantino SJ, Gracie DJ, Ford AC, Published December 2020 in the Lancet Gastroenterology and Hepatology

Safely restarting GI endoscopy in the era of COVID-19

Bu'Hussain Hayee, Mo Thoufeeq, Colin J Rees, Ian Penman, James East, Published December, 2020 in the Gut